Bipoláris zavar: ki dolgozik rajta

Intézményenként egy kártya. Válassz célpontot, és csak az azon dolgozó csoportok maradnak.

• Minden célpont
• GLP-1 0
• BDNF 0
• NMDA 1
• SGLT2 1
• PI3K 0
• AQP4 0
• PCSK9 0
• PPAR 0
• TNF 0
• AKT 0
• BRD4 0
• G6PD 0
• IGF1R 0
• IL-1 0
• IL-17 0
• IL-6 0
• MAPT 0
• NLRP3 0
• NRF2 0
• SIRT1 0
• TFEB 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-ERC

  The cerebellum: a transdiagnostic personalised target for neuromodulation in psychiatry (CLOVIS)

  Universite Paris Xii Val de Marne· Creteil, Franciaország· EU contribution 1 499 500 EUR· until 2031. aug.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-EIC-ACC

  Callyope Copilot: Speech Foundation Model for Transdiagnostic Mental Health Assessment & Relapse Mitigation (CALLYOPECOPILOT)

  Callyope· Neuilly sur Seine, Franciaország· EU contribution 2 498 053 EUR· until 2028. máj.

• European Commission (Horizon Europe) · HORIZON-ERC

  Personalized Genetic Risk Profile: A New Tool to Guide Prevention of Serious Mental Illness (PersonalRiskProfile)

  Stichting Amsterdam Umc· Amsterdam, Hollandia· EU contribution 1 499 891 EUR· until 2030. dec.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Synaptic signatures: Understanding thalamocortical circuit specification and disease vulnerability (ThalamoLinkIT)

  Vib Vzw· Zwijnaarde - Gent, Belgium· EU contribution 200 400 EUR· until 2027. márc.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-RIA

  Synapsing Mental Disorders and Neurodegenerative diseases: Towards more effective diagnosis and management of psychiatric symptoms (SYNAPSING)

  Institut de Recerca de L'hospital de la Santa Creu I Sant Pau Fundacion· Barcelona, Spanyolország· EU contribution 6 999 922 EUR· until 2029. dec.· 9 countries

5 of 10 running projects, newest first. Listed amounts together: 29,5 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 6
• Mendelian Randomization Analysis 52
• CRISPR-Cas Systems 2
• Gene Expression Profiling 23
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 2
• Exome Sequencing 3
• Proteomics 17
• Metabolomics 8
• Mass Spectrometry 3
• Immunohistochemistry 1
• Positron-Emission Tomography 13
• Magnetic Resonance Imaging 190
• Machine Learning 59
• Deep Learning 9
• Cohort Studies 96
• Genome-Wide Association Study 107

• Investigating Causal Relationships Between Major Mental Disorders and Hypertension Subtypes and Their Complications: A Mendelian Randomization Study.

  Genes Brain Behav, 2026. dec.

• Psychiatric disorders and gynecologic tumors: A 2-sample Mendelian randomization study of 20 exposure-outcome pairs.

  Medicine (Baltimore), 2026. szept.

• Mapping the Immune cell-specific gene regulatory network in bipolar disorder: A framework from scTWMR to exploratory drug-target annotation.

  Psychiatry Res, 2026. szept.

• Causal association between cataract and psychiatric disorders: A bidirectional 2-sample Mendelian randomization study.

  Medicine (Baltimore), 2026. aug.

• Does Toxoplasma gondii infection have a causal impact on human psychopathology? A Mendelian randomization analysis.

  PLoS Pathog, 2026. aug.

• Unravelling the role of alanine in mental disorders: a Mendelian randomisation study.

  J Nutr Sci, 2026. júl.

• Glucagon-like peptide-1 receptor activation and mental health: a drug-target mendelian randomization study.

  Transl Psychiatry, 2026. júl.

• Relationship between mental disorders and non-traumatic cerebral hemorrhage: cross-sectional analysis and mendelian randomization.

  PeerJ, 2026. jún.

• Unraveling the bidirectional association between mental disorders and prostatitis: insights from a genetic perspective.

  Can J Urol, 2026. jún.

• Cytomegalovirus-related immune activation and major neuropsychiatric disorders: Mendelian randomization and bulk transcriptomic validation.

  Psychiatry Res, 2026. jún.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.